EUVIMEDEUVIMED entdecken
Crossref

Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists

Mégane Fernandez, Tiffany Pezier, Stylianos Papadopoulos, Fabrice Laurent, Catherine Werts, Sonia Lacroix-Lamandé iD

Journal of Leukocyte Biology · 2024

DOI: 10.1093/jleuko/qiae140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Mégane Fernandez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infectiologie et Santé Publique, Université de Tours, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, F-37380 N…. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Animals, Newborn, Toll-Like Receptor 6. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: the French Institut Carnot France Futur Elevage, Microbes Santé, Région Centre-Val de Loire.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

By providing innate immune modulatory stimuli, the early-life immune system can be enhanced to increase resistance to infections. Activation of innate cell surface receptors called pattern recognition receptors by Toll-like receptor (TLR) ligands is one promising approach that can help to control infections as described for listeriosis and cryptosporidiosis. In this study, the effect of TLR2/TLR1 and TLR2/TLR6 agonists was compared when injected into neonatal mice. Surprisingly, the stimulation of TLR2/TLR6 led to the death of the neonatal mice, which was not observed in adult mice. The TLR2/TLR6 agonist administration induced higher systemic and intestinal inflammation in both adult and neonatal mice when compared with TLR2/TLR1 agonist. The mortality of neonatal mice was interferon γ dependent and involved the intestinal production of interleukin-22 and interleukin-17A. This study clearly demonstrates that targeting TLRs as new control strategy of neonatal infections has to be used with caution. Depending on its heterodimeric form, TLR2 stimulation can induce more or less severe adverse effects relying on the age-related immune functions of the host.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 2Animals, NewbornToll-Like Receptor 6AnimalsMiceMice, Inbred C57BLInterleukin-22IntestinesInflammationInterleukin-17InterleukinsInterferon-gammaLipopolysaccharidesToll-Like Receptor 1

Stichwörter der Autor:innen

TLR2TLR6hyper-Inflammationneonatal micepam2CSK4

Substanzen

Toll-Like Receptor 2Toll-Like Receptor 6Interleukin-22Tlr2 protein, mouseInterleukin-17InterleukinsInterferon-gammaTlr6 protein, mouseLipopolysaccharidesToll-Like Receptor 1

Autor:innen und Institutionen

  • Infectiologie et Santé Publique, Université de Tours, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, F-37380 Nouzilly, France.
  • Centre National de la Recherche Scientifique UMR6047, Institut National de la Santé et de la Recherche Médicale U1306, Unité de Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur, Université Paris Cité, Par…

ORCID-Profile: Sonia Lacroix-Lamandé

Förderung

  • the French Institut Carnot France Futur Elevage
  • Microbes Santé
  • Région Centre-Val de Loire
  • Université Paris Cité
  • BioSPC

Zitieren

APA

Fernandez, M., Pezier, T., Papadopoulos, S., Laurent, F., Werts, C., & Lacroix-Lamandé, S. (2024). Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae140

Vancouver

Fernandez M, Pezier T, Papadopoulos S, Laurent F, Werts C, Lacroix-Lamandé S. Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae140

BibTeX
@article{Fernandez2024,
  author = {Fernandez, Mégane and Pezier, Tiffany and Papadopoulos, Stylianos and Laurent, Fabrice and Werts, Catherine and Lacroix-Lamandé, Sonia},
  title = {Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists},
  journal = {Journal of Leukocyte Biology},
  year = {2024},
  doi = {10.1093/jleuko/qiae140}
}
Kostenlos starten →